Spots Global Cancer Trial Database for fap
Every month we try and update this database with for fap cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA | NCT00510692 | Familial Adenom... FAP | Eicosapentanoic... Endoscopy Biopsies taken Placebo | 18 Years - | S.L.A. Pharma AG | |
| Hereditary Colorectal and Associated Tumor Registry Study | NCT00633607 | Lynch Syndrome FAP Hereditary Diff... Juvenile Polypo... Peutz-Jeghers S... | Research Regist... | 8 Years - 100 Years | University of Pittsburgh | |
| FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER) | NCT05432193 | Pancreatic Duct... Colorectal Canc... Esophageal Canc... Melanoma (Skin) Soft Tissue Sar... Head and Neck S... Cholangiocarcin... | [Ga-68]-PNT6555 [Lu-177]-PNT655... | 18 Years - | POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company | |
| Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma | NCT01722149 | Malignant Pleur... | Adoptive Transf... | 18 Years - 75 Years | University of Zurich | |
| Evaluation of Fapi-pet in Prostate Cancer. | NCT05192694 | Prostate Cancer | Computed tomogr... | 18 Years - 100 Years | Helsinki University Central Hospital | |
| Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP) | NCT00585312 | Adenomatous Pol... | Celecoxib Placebo | 10 Years - 17 Years | Pfizer | |
| The Role of Fibroblast Activation in Uterine Fibroid | NCT03444987 | Uterine Fibroid | Measurement of ... | - 50 Years | Assiut University | |
| Ileal Pouch-Anal Anastomosis Registry | NCT01026480 | Ileal Pouch-Ana... | - | Boston Medical Center | ||
| The Role of Fibroblast Activation in Uterine Fibroid | NCT03444987 | Uterine Fibroid | Measurement of ... | - 50 Years | Assiut University | |
| Turmeric Supplementation on Polyp Number and Size in Patients With Familial Adenomatous Polyposis. | NCT03061591 | Familial Adenom... FAP FAP Gene Mutati... | Wholistic Turme... Placebo | 18 Years - 70 Years | Tel-Aviv Sourasky Medical Center | |
| Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA | NCT00510692 | Familial Adenom... FAP | Eicosapentanoic... Endoscopy Biopsies taken Placebo | 18 Years - | S.L.A. Pharma AG | |
| Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma | NCT01722149 | Malignant Pleur... | Adoptive Transf... | 18 Years - 75 Years | University of Zurich | |
| Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma | NCT05262855 | PDAC - Pancreat... FAP | [68Ga]FAPI-46 | 18 Years - | SOFIE | |
| FAPI-PET for Tumor Detection | NCT04571086 | Malignant Neopl... | 18 Years - | University Hospital, Essen | ||
| Preventive Anti-inflammatory Diet to Reduce Gastro-intestinal Inflammation in FAP Patients: a Prospective Pilot Study | NCT04552405 | Familial Adenom... | Anti-inflammato... | 18 Years - | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma | NCT05262855 | PDAC - Pancreat... FAP | [68Ga]FAPI-46 | 18 Years - | SOFIE | |
| Effect of EPA-FFA on Polypectomy in Familial Adenomatous Polyposis | NCT03806426 | Familial Adenom... | Eicosapentaenoi... Placebo | 18 Years - 65 Years | S.L.A. Pharma AG | |
| Non-Surgical Management of Attenuated and Deleterious (Classical) Familial Adenomatous Polyposis: A Long-term Surveillance Program | NCT02747862 | Attenuated Fami... Deleterious Fam... | Chart Review | - | M.D. Anderson Cancer Center | |
| FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER) | NCT05432193 | Pancreatic Duct... Colorectal Canc... Esophageal Canc... Melanoma (Skin) Soft Tissue Sar... Head and Neck S... Cholangiocarcin... | [Ga-68]-PNT6555 [Lu-177]-PNT655... | 18 Years - | POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company | |
| Ileal Pouch-Anal Anastomosis Registry | NCT01026480 | Ileal Pouch-Ana... | - | Boston Medical Center | ||
| Preventive Anti-inflammatory Diet to Reduce Gastro-intestinal Inflammation in FAP Patients: a Prospective Pilot Study | NCT04552405 | Familial Adenom... | Anti-inflammato... | 18 Years - | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Evaluation of Fapi-pet in Prostate Cancer. | NCT05192694 | Prostate Cancer | Computed tomogr... | 18 Years - 100 Years | Helsinki University Central Hospital | |
| The Role of Fibroblast Activation in Uterine Fibroid | NCT03444987 | Uterine Fibroid | Measurement of ... | - 50 Years | Assiut University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
